Yao-Ning Chan

Title: Yao-Ning Chan: Innovator in Cancer Prognosis Analysis

Introduction

Yao-Ning Chan is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of cancer research through his innovative inventions. His work focuses on developing analytical methods that can improve the prognosis of cancer radiotherapy.

Latest Patents

Yao-Ning Chan holds a patent for an "Analyzer and analytical method for predicting prognosis of cancer radiotherapy." This invention provides an analyzer that includes a detection device and an arithmetic device. The detection device can identify expression levels of various microRNAs (miRNAs) in a specimen. The miRNAs involved in this analysis include hsa-miR-130a-3p, hsa-miR-215-5p, hsa-miR-29a-3p, hsa-let-7b-5p, hsa-miR-19b-3p, hsa-miR-374a-5p, and hsa-miR-148a-3p. The arithmetic device utilizes logistic regression to analyze the expression levels of these miRNAs, allowing for the determination of whether the prognosis of cancer radiotherapy is poor or good. Yao-Ning Chan has 1 patent to his name.

Career Highlights

Throughout his career, Yao-Ning Chan has worked at National Central University, where he has contributed to various research projects. His expertise in cancer prognosis analysis has positioned him as a valuable asset in the field of medical research.

Collaborations

Yao-Ning Chan has collaborated with notable colleagues, including Nian-Han Ma and Tao-Sheng Chung. These collaborations have further enhanced his research and development efforts in cancer prognosis.

Conclusion

Yao-Ning Chan's innovative work in cancer prognosis analysis demonstrates his commitment to improving patient outcomes in cancer treatment. His contributions through his patent and collaborations highlight the importance of research in advancing medical science.